After cerebral ischemia, the changes in the intracellular microenvironment trigger the NLRP3 inflammasome (NLRP3/ASC/CASPASE-1) activation, which leads to the secretion of IL-1β and IL-18 and finally mediated cell death. The gene discussed is IL18; the disease is brain ischemia.